neohts

neohts | Joined since 2013-07-25

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

2,046

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
2,046
Past 30 days
59
Past 7 days
5
Today
2

User Comments
Stock

53 minutes ago | Report Abuse

https://www.thestar.com.my/business/business-news/2024/03/29/thailand-presses-case-for-casinos-to-boost-revenues-tourism-and-jobs

Thailand presses case for casinos to boost revenues, tourism and jobs

"We have to admit that there is illegal gambling in the country, we are trying to get rid of (it) but it cannot be wiped out, so we have to rethink and see that it is time for this," Deputy Finance Minister Julapun Amornvivat told reporters, adding Singapore would be a model to emulate.

Stock

4 hours ago | Report Abuse

https://theedgemalaysia.com/node/696471

Genting Singapore may bid for Thailand casino — Maybank IB
KUALA LUMPUR (Jan 7): Genting Singapore may bid for a casino and integrated resort licence in Thailand, should the Thai government open up the industry, according to Maybank Investment Bank Research (Maybank IB).

Citing the research house, industry magazine Inside Asian Gaming (IAG) said the company would look to form a joint venture for a Thai IR licence, based on its previous exploits in Korea and Japan.

Stock

2 days ago | Report Abuse

https://www.thestar.com.my/aseanplus/aseanplus-news/2024/03/27/thailand-can-lift-tourism-revenue-by-legalising-casinos-study

Thailand can lift tourism revenue by legalising casinos ?
I remember Genting Singapore apply for Casino license in Thailand ?

Stock
Stock

6 days ago | Report Abuse

Still washing plate and slowly accumulating before next move. Time Will come and be patient.
Sooner or later TauRX going to approve and we will be laughing all the way to the bank.

Stock

1 week ago | Report Abuse

share price already very high.
Last quarter result not very good.
Electric car not easy to sell in Malaysia because very few places can charge car.

Stock

1 week ago | Report Abuse

Once TauRX approve, Genting Berhad going to Limit up.
I am not joking. If you sell now you are going the regret the rest of your life.

Stock

1 week ago | Report Abuse

Why selling when there are a lots of good news to be announce soon ?

Stock

1 week ago | Report Abuse

It's normal after Dividend EX date.
Next week or Next month it will go back to 4.90 or 5.00.

Stock

1 week ago | Report Abuse

4.92 closing before 5 pm eat all.

Stock

1 week ago | Report Abuse

So much effort have been done on TauRX and Genting will try their best to push for approval.
Just wait for good news. Hold and don't sell.

Stock

1 week ago | Report Abuse

Holding power will win.
TauRX shouldn't be a problem getting approved.

Stock

1 week ago | Report Abuse

Good support at RM5.
Next week all the best.

Stock

2 weeks ago | Report Abuse

Still washing.
Washing until water is very clear then start moving up.

Stock

2 weeks ago | Report Abuse

Just hold or buy more. No need to do anything. Just wait for TauRX. Heng Ah, Ong Ah, Huat Ah.

Stock

2 weeks ago | Report Abuse

GenP and GenM dividend will contribute to GenB CASH on hand.

Stock

2 weeks ago | Report Abuse

A very good close. Washing all weak holders. Continue washing for another few days. Next target price will be 5.30, then 5.50 then 6.00. keep washing and continue go higher.

Stock

2 weeks ago | Report Abuse

Washing before go higher.

Stock

2 weeks ago | Report Abuse

https://theedgemalaysia.com/node/704256

Genting’s Resorts World Bet achieved US$500,000 wagering revenue in February — report

KUALA LUMPUR (March 12): Resorts World Bet, an offshoot of the Genting group, achieved US$500,000 (RM2.34 million) in wagering revenue, as online sports wagering revenue in the New York state rose 21% in February, with a hold percentage of 7.4%, slightly lower than industry standards.

In a report on Sunday, North America's gambling industry news source CDC Gaming said handle (money bets) was also up 21%, at almost US$1.8 billion wagered.

The report said revenue before taxes was US$131.4 million.
One operator, Fanatics Sportsbet, participated in the market for only one day, having launched on Feb 29.

Although substantially increased handle was seen at DraftKings (up 24%), FanDuel (22%), and BetMGM (20%), only the first two increased revenue.

BetMGM lost ground in revenue, while Caesars Sportsbook ceded both handle and revenue alike.

DraftKings grossed US$53.4 million on US$608 million in handle, a 59% surge.
FanDuel led in both handle (US$720 million) and revenue (US$63.4 million), the latter a 19% increase.

BetMGM booked US$130 million in wagers, but realised revenue of only US$600,000.

Stock

2 weeks ago | Report Abuse

Washing before go higher.

Stock

2 weeks ago | Report Abuse

https://theedgemalaysia.com/node/704204

According to Bloomberg, of the 16 analysts covering the stock, 14 have “buy” calls on Genting while two recommended “hold”.

Worth noting is that Genting’s share price rally comes after Maybank Investment Bank Research said its target price for the group could be revised upward to RM9.40 under the blue sky scenario where TauRx’s hydromethylthionine mesylate (HMTM) drug is approved and the pharmaceutical company is valued at US$15 billion (RM70.23 billion), up from US$1 billion currently.

HLIB has upgraded its target price for Genting to RM7.12, from RM6.96 previously, due to the group being undervalued as it does not sufficiently capture the potential recovery of both its subsidiaries, Genting Singapore Ltd and Genting Malaysia Bhd.

Stock

2 weeks ago | Report Abuse

Genting Berhad management is very confident they will be getting TauRX approval. That is reason insiders pushing the share price up before announcement.

Stock

2 weeks ago | Report Abuse

Waiting for TauRX announcement. Once approved. Maybank TP 9.40.

Stock

2 weeks ago | Report Abuse

AngTayKor....I support you. Buy more and laughing all the way to the Bank.

Stock

2 weeks ago | Report Abuse

GenM got nothing to do with TauRX. Only GenB.

Stock

2 weeks ago | Report Abuse

I think Genting Berhad insider already know the good news. Pending official announcement.

Stock

2 weeks ago | Report Abuse

Continue holding. Turbo Engine just started.

Stock

2 weeks ago | Report Abuse

https://theedgemalaysia.com/node/703916

Genting’s target price could be raised to as high as RM9.40 under a blue sky scenario, where HMTM is approved and TauRx is valued at US$15 billion (RM70.3 billion) without discount, the research house added.

TP RM9.40

Stock

2 weeks ago | Report Abuse

We are pleased to confirm receipt of investigative new drug (IND) approval from the National Medical Products Administration (NMPA) in China for study TRx-237-801. dMed-Clinipace, a global CRO based in Shanghai, has been selected as the research partner for this study.
We estimate that 60% of the global burden of AD is in Asian countries compared with only 12% in Europe and US combined.

Stock

2 weeks ago | Report Abuse

Submitted for approval. Once approved no problem breaking RM7.

Stock

2 weeks ago | Report Abuse

Eli Lilly got any thing to do with TauRX?

Stock

2 weeks ago | Report Abuse

Cannot do anything. Just wait until the durian drop.

Stock

3 weeks ago | Report Abuse

When can get official approval ? soon ?

Stock

3 weeks ago | Report Abuse

Afternoon closing price very important.

Stock

3 weeks ago | Report Abuse

https://theedgemalaysia.com/node/703916

KUALA LUMPUR (March 8): TauRx Pharmaceuticals Ltd, the 20%-owned associate of Genting Bhd, said new data show that its trial drug to combat Alzheimer's disease has “sustained benefits” across the disease spectrum from early to moderate dementia.

The new 24-month data from the third phase of the so-called LUCIDITY trial of hydromethylthionine mesylate (HMTM) showed “significantly” reduced disease progression in participants, TauRx said in a statement following a presentation at a conference in Portugal.

Genting’s target price could be raised to as high as RM9.40 under a blue sky scenario, where HMTM is approved and TauRx is valued at US$15 billion (RM70.3 billion) without discount, Maybank said.

Stock

3 weeks ago | Report Abuse

https://www.nst.com.my/amp/business/2022/06/804468/genting-set-early-monetisation-associate-firm-taurx

RHB Research said TauRx could contribute RM1.3 billion-RM4.3 billion to Genting's financial year 2024 (FY24)-FY26 earnings, assuming a 10 per cent net margin.

KUALA LUMPUR: Merger and acquisition (M&A) of Genting Bhd's 20.3 per cent-owned research and development (R&D) associate TauRx Pharmaceuticals Ltd could allow for faster monetisation versus initial public offering (IPO), RHB Research said.
The firm said while Genting did not comment on its strategy with regards to its TauRx stake, any option of value realisation or monetisation was definitely a positive after having invested in the firm since November 2012.
"For TauRx to IPO, it would need to first commercialise its lead investigative oral drug, HMTM, in 2023 and undertake listing in 2024 or later.

"Conversely, we think M&A or in-licensing agreements may allow for earlier monetisation of Genting's stake, given that large pharmaceutical firms may have M&A interest in TauRx in order to possess the world's only effective Alzheimer's treatment.

"As a plus, M&A could allow TauRx to leverage on such firms' resources to expedite HMTM speed to market," it said in a note today. RHB Research said the HMTM drug would need to undergo 12 months of open-label trials – it could seek regulatory approvals for this Alzheimer's drug before the trial's conclusion.

RHB Research said TauRx could contribute RM1.3 billion-RM4.3 billion to Genting's financial year 2024 (FY24)-FY26 earnings, assuming a 10 per cent net margin.
It could also fetch an upside of RM3.47-RM13.88 a share share based on 10x price to earnings ratio (P/E) on our base and bull cases for FY24 earnings," it said.

RHB said this could translates to hypothetical target price of RM9.84-RM20.25 for Genting.

Stock

3 weeks ago | Report Abuse

Genting always got disappointment and surprises.

Stock

3 weeks ago | Report Abuse

Don't give up 愛拼才會贏.

Stock

3 weeks ago | Report Abuse

Genting Berhad
TauRX tomorrow presentation day.
愛拼才會贏

Stock

3 weeks ago | Report Abuse

Interesting.
Afternoon not sure got magic show ?

Stock

3 weeks ago | Report Abuse

https://www.businesstoday.com.my/2024/03/05/all-eyes-on-gentings-taurx-alzheimer-phase-3-trial/

On 7 Mar 2024, Genting Berhad’s 20%-owned TauRx will present full results from its Phase 3 LUCIDITY trial of HMTM that is designed to combat Alzheimer’s disease. It has initiated regulatory engagement in the United Kingdom and the United States for product approval.

Under a ‘blue sky’ scenario where HMTM is approved and TauRx is valued at USD15b with no discount ascribed to it, Maybank IB says GENT TP could be raised to MYR9.40. As for now the house estimates MYR5.73 TP unchanged but encourages investors to BUY now to position ahead.

Stock

3 weeks ago | Report Abuse

AngTayKor
Your update is very important and useful. Please continue.

Stock

3 weeks ago | Report Abuse

I would have sold all my Genting long time ago.
It's because of TauRX, I am still holding until now.
Hopeless hope. Very disappointed.

Stock

3 weeks ago | Report Abuse

Maybank IB advises investors to look at Genting given its involvement in life sciences

NST Tue, Mar 05, 2024 12:12pm - 51 minutes .....latest news just came in.

Stock

3 weeks ago | Report Abuse

Q3 result not yet out ?

Stock

3 weeks ago | Report Abuse

AngTayKor...... thanks

Stock

3 weeks ago | Report Abuse

TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), announced today that the company will present the 24-month data from its Phase III LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the upcoming AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference from 5-9 March 2024, in Lisbon, Portugal.

Tomorrow.

Stock

3 weeks ago | Report Abuse

1) sell that land in US fast.
2) IPO Las Vegas hotels and Casino.
3) TauRX launching.
Genting management please work harder and faster. Wake up.

Stock

3 weeks ago | Report Abuse

Too many containers only a few covers. Hoping for the best.

Stock

4 weeks ago | Report Abuse

Kindly be advised of the following :

1) The above Company's securities will be traded and quoted "Ex - Dividend” as from: 20 Mar 2024
2) The last date of lodgment : 21 Mar 2024
3) Date Payable : 19 Apr 2024